BioCentury | Oct 3, 2019
Targets & Mechanisms

Stimulating heart regeneration following injury

A multi-omic study of regenerating neonatal hearts has uncovered novel therapeutic targets for cardiac injury post myocardial infarction. Study leader Eric Olson said the findings serve as a resource for understanding the DNA sequences and...
BioCentury | Feb 10, 2014
Company News

Regenerative Sciences gene/cell therapy, musculoskeletal news

...Appeals for the District of Columbia. The appeals court upheld a decision in USA v. Regenerative Sciences LLC...
...withdrawn from a patient, concentrated and injected back into the patient on the same day. Regenerative Sciences LLC...
BioCentury | Feb 7, 2014
Company News

Court reaffirms FDA authority over autologous cells

...court upheld a decision in USA v. Regenerative Sciences that the Cultured Regenexx Procedure (Regenexx-C) from Regenerative Sciences LLC...
BioCentury | Nov 12, 2012
Company News

Parios Regenerative Sciences, Brown University deal

...care. The university declined to comment, while Parios could not be reached for comment. Parios Regenerative Sciences...
BioCentury | Jul 30, 2012
Company News

Regenerative Sciences musculoskeletal news

...A judge in the U.S. District Court for the District of Columbia said Regenerative Sciences' cultured cell...
...term "drug" refers to any human cell, tissue, or cellular or tissue-based product, which covers Regenerative Sciences'...
...2010, the Justice Department filed a complaint for the injunction on behalf of FDA after Regenerative Sciences...
BioCentury | May 21, 2012
Financial News

Regenerative Sciences completes venture financing

Regenerative Sciences Inc. , Broomfield, Colo. Business: Gastrointestinal Date completed: 5/14/12 Type: Venture financing Raised: $2 million Investor: Private investor WIR Staff Gastrointestinal...
BioCentury | Feb 13, 2012
Company News

BioRestorative Therapies, Regenerative Sciences LLC deal

...expected to close in March. Details were not disclosed. BioRestorative Therapies Inc. (OTCQB:BRTX), Jupiter, Fla. Regenerative Sciences LLC...
BioCentury | Aug 16, 2010
Clinical News

Cultured cell product regulatory update

...On behalf of FDA, the Justice Department filed a complaint for an injunction against Regenerative Sciences in...
...stem cells can be classified as drugs when used as part of a medical practice. Regenerative Sciences...
...bone marrow or synovial fluid and mixed with drug products ex vivo before being re-injected. Regenerative Sciences LLC...
BioCentury | May 18, 2009
Company News

NeoStem, Regenerative Sciences Inc. deal

...Asia by year end. Regenerative Sciences is eligible for royalties. NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Regenerative Sciences...
Items per page:
1 - 9 of 9
BioCentury | Oct 3, 2019
Targets & Mechanisms

Stimulating heart regeneration following injury

A multi-omic study of regenerating neonatal hearts has uncovered novel therapeutic targets for cardiac injury post myocardial infarction. Study leader Eric Olson said the findings serve as a resource for understanding the DNA sequences and...
BioCentury | Feb 10, 2014
Company News

Regenerative Sciences gene/cell therapy, musculoskeletal news

...Appeals for the District of Columbia. The appeals court upheld a decision in USA v. Regenerative Sciences LLC...
...withdrawn from a patient, concentrated and injected back into the patient on the same day. Regenerative Sciences LLC...
BioCentury | Feb 7, 2014
Company News

Court reaffirms FDA authority over autologous cells

...court upheld a decision in USA v. Regenerative Sciences that the Cultured Regenexx Procedure (Regenexx-C) from Regenerative Sciences LLC...
BioCentury | Nov 12, 2012
Company News

Parios Regenerative Sciences, Brown University deal

...care. The university declined to comment, while Parios could not be reached for comment. Parios Regenerative Sciences...
BioCentury | Jul 30, 2012
Company News

Regenerative Sciences musculoskeletal news

...A judge in the U.S. District Court for the District of Columbia said Regenerative Sciences' cultured cell...
...term "drug" refers to any human cell, tissue, or cellular or tissue-based product, which covers Regenerative Sciences'...
...2010, the Justice Department filed a complaint for the injunction on behalf of FDA after Regenerative Sciences...
BioCentury | May 21, 2012
Financial News

Regenerative Sciences completes venture financing

Regenerative Sciences Inc. , Broomfield, Colo. Business: Gastrointestinal Date completed: 5/14/12 Type: Venture financing Raised: $2 million Investor: Private investor WIR Staff Gastrointestinal...
BioCentury | Feb 13, 2012
Company News

BioRestorative Therapies, Regenerative Sciences LLC deal

...expected to close in March. Details were not disclosed. BioRestorative Therapies Inc. (OTCQB:BRTX), Jupiter, Fla. Regenerative Sciences LLC...
BioCentury | Aug 16, 2010
Clinical News

Cultured cell product regulatory update

...On behalf of FDA, the Justice Department filed a complaint for an injunction against Regenerative Sciences in...
...stem cells can be classified as drugs when used as part of a medical practice. Regenerative Sciences...
...bone marrow or synovial fluid and mixed with drug products ex vivo before being re-injected. Regenerative Sciences LLC...
BioCentury | May 18, 2009
Company News

NeoStem, Regenerative Sciences Inc. deal

...Asia by year end. Regenerative Sciences is eligible for royalties. NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Regenerative Sciences...
Items per page:
1 - 9 of 9